Divi's Laboratories Limited has informed the National Stock Exchange of India Limited and BSE Limited that it has set August 2nd, 2024 as the record date for determining shareholders' eligibility to receive a proposed dividend.
The company's board of directors had previously recommended a dividend of ₹30 per equity share (1500%) for the financial year 2023-24. However, this dividend is subject to approval by the shareholders at the company's 34th Annual General Meeting (AGM), scheduled for August 12th, 2024.
The AGM will be conducted through video conferencing and other audio-visual means, ensuring accessibility for all shareholders. If approved, the dividend payment will be a significant return for investors and reflect the company's strong financial performance in the past year.
Leave a comment